The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 17, 2026

Filed:

Nov. 18, 2019
Applicants:

Zikani Therapeutics, Inc., Watertown, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Roger B. Clark, Lexington, MA (US);

Richard Alm, Berlin, MA (US);

Wesley Francis Austin, Cambridge, MA (US);

Philip Hogan, Brighton, MA (US);

Ivan Jewett, Boston, MA (US);

Sushmita D. Lahiri, Lexington, MA (US);

Jonathan F. Lawrence, Somerville, MI (US);

Xiben Li, Lexington, MA (US);

Shuhao Shi, Madison, CT (US);

Wenying Wang, Boston, MA (US);

Yoshitaka Ichikawa, Cambridge, MA (US);

Andrew G. Myers, Boston, MA (US);

Ziyang Zhang, San Francisco, CA (US);

Peter Niels Carlsen, Claymont, DE (US);

Andre Sanchez, Bradenton, FL (US);

Ganapathy Dhandapani, Tunisia, IN;

Thrimurtulu Neetipalli, Arlington, MA (US);

Md. Ataur Rahman, Arlington, MA (US);

Thomas Lepitre, Montreal, CA;

Assignees:

Zikani Therapeutics , Inc., Watertown, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 17/00 (2006.01); A61P 31/04 (2006.01);
U.S. Cl.
CPC ...
C07H 17/00 (2013.01); A61P 31/04 (2018.01);
Abstract

Provided are 13-membered macrolides for the treatment of infectious diseases. The 13-membered macrolides described herein are azaketolides. Also provided are methods for preparing the 13-membered macrolides, pharmaceutical compositions comprising the 13-membered macrolides, and methods of treating infectious diseases, and in particular, disease resulting from Gram negative bacteria using the disclosed macrolides. Formula (I)


Find Patent Forward Citations

Loading…